4Atahan IL,Onal C,Ozyar E,et al.Long-term outcome and prognostic factors in patients with cervical carcinoma:a retrospective study.Int J Gynecol Cancer,2007,17(4):833-842.
5Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.J Natl Cancer Inst,2000,92(3):205-216.
6Green JA,Kirwan JM,Tierney JF,et al.Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and meta-analysis.Lancet,2001,358(9284):781-786.
7Koh DM,Scurr E,Collins D,et al.Predicting response of colorectal hepatic metastasis:value of pretreatment apparent diffusion coefficients.AJR Am J Roentgenol,2007,188(4):1001-1008.
9Guo AC,Cummings TJ,Dash RC,et al.Lymphomas and high-grade astrocytomas:comparison of water diffusibility and histologic characteristics.Radiology,2002,224(1):177-183.
10Koh DM,Collins DJ.Diffusion-weighted MRI in the body:applications and challenges in oncology.AJR Am J Roentgenol,2007,188(6):1622-1635.
1VAN DEN BOSCH S, ALFRED W1GJES J. Long-term canc-er-specific survival in patients with high-risk, non-muscle-in- vasive bladder cancer and tumour Progression: a systematic review[J]. Eur Urol, 2011. 60(3) : 493 -500.
2GIANNARINI G, PETRALIA G, THOENY H C. Potential and Iimitations of diffusion-weighted magnetic resonance ima- ging in kidney, prostate, and bladder cancer including pel- vic Iymph node staging: a critical analysis of the literature [J]. EurUrol, 2012, 61(2): 326-340.
3BABJUK M, OOSTERLINCK W, SYLVESTER R, et al. EAU guideI I nes on non-muscle-invasive Urothelial carcino- ma of the bladder, the 2011 update[J]. EurUrol, 2011, 59(6) : 997 - 1008.
4MOSES K A, ZHANG J, HRICAK H, et alo Bladdercan- cer imaging: an updateU[J]. Curr Opin Urol, 2011, 2 1 (5) : 393 - 397.
